Events & Presentations
Upcoming Events
- Upcoming Events
- Archive
-
Aug 10, 2022Publication of the Interim Report for the First Half 2022 (after 5:00 PM CEST)Nov 9, 2022Publication of the Interim Report for the First Nine Months 2022 (after 5:00 PM CET)Dec 31, 2022Financial Calendar Year End
-
May 11, 2022Publication of the Interim Report for the First Quarter 2022 (after 5:00 PM CEST)
On May 11, Genmab announced financial results for the first three months of 2022.
Mar 29, 2022 at 2:00 PM CESTAnnual General Meeting 2022The Annual General Meeting 2022 took place on Tuesday, March 29.Feb 16, 2022Publication of the Annual Report for 2021 (after 5:00 PM CET)On February 16, Genmab announced its full year 2021 financial results.
Feb 14, 2022Deadline for shareholders to submit any items for consideration for the agenda of the Annual General Meeting in writing to the Board of DirectorsJan 12, 2022 from 9:00 AM to 9:40 AM EST40th Annual J.P. Morgan Healthcare ConferenceDec 31, 2021Financial Calendar Year EndDec 14, 2021 at 2:00 PM EST2021 Virtual R&D Update and ASH Data ReviewGenmab hosted a virtual R&D Update and ASH Data Review on Tuesday, December 14, 2021. A replay of the event is available here.
Nov 18, 2021 at 9:00 AM CETJefferies Virtual London Healthcare ConferenceFireside Chat with President and CEO, Jan van de Winkel.Nov 10, 2021Publication of the Interim Report for the First Nine Months 2021 (after 5:00 PM CET)On November 10, Genmab announced financial results for the first nine months of 2021.
Sep 9, 2021 at 8:00 AM EDTMorgan Stanley 19th Annual Global Healthcare ConferenceFireside Chat with President and CEO, Jan van de Winkel.
Aug 11, 2021Publication of the Interim Report for the First Half 2021 (after 5:00 PM CEST)Genmab presented its first half 2021 financial results on August 11, 2021.Jun 8, 2021 from 3:50 PM to 4:30 PM EDTGoldman Sachs 42nd Annual Global Healthcare ConferenceFireside Chat with Chief Financial Officer, Anthony Pagano and Chief Development Officer, Judith Klimovsky
May 5, 2021Publication of the Interim Report for the First Quarter 2021 (after 5:00 PM CEST)On May 5, Genmab announced financial results for the first three months of 2021.Apr 13, 2021Annual General Meeting 2021Genmab A/S’ Annual General Meeting 2021 took place on Tuesday, April 13.Mar 23, 2021 from 3:30 PM to 4:15 PM CETInteractive Q&A Session with Genmab's CEOMar 1, 2021Deadline for shareholders to submit any items for consideration for the agenda of the Annual General Meeting in writing to the Board of DirectorsFeb 23, 2021 from 11:00 AM to 12:00 AM ESTPublication of the Annual Report for 2020 -
-